Fecal Lactoferrin As A Diagnostic and Prognostic Marker in Egyptian IBD Patients

Comparative study the levels of plasma transforming growth factor-β1, serum crp, fecal lactoferrin, and fecal calprotectin as biomarkers for disease activity in Egyptian patients

Assessment of Fecal Calprotectin level in Inflammatory, Infectious and Malignant Gastrointestinal Diseases

Epidemiological and Clinical Characteristics of Inflammatory Bowel Disease in Egyptian Patients at the Nile Delta: A Single-Center Study

A Study of the Gut Microbiome in Egyptian Patients with active Crohn’s Disease

Use of Fecal Calprotectin as A Predictor of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Egyptian Patients

Clinico-Epidemiological Study of Colorectal Cancer Patients Diagnosed at Endoscopy Unit of Two University Hospitals in Cairo

Predictive value of trefoil factor 3 for identifying activity in ulcerative colitis patients: a comparison with fecal calprotectin and C-reactive protein

Evaluation of The Role of Fecal Microbiota Transplantation in The Management of Ulcerative Colitis in Egyptian Patients

Serum Calprotectin: A promising Biomarker for Inflammatory Bowel Disease [IBD]